The latest thoracic oncology news
Many countries with national healthcare systems or payers such as insurance companies use cost-effectiveness analyses…
NSCLC is the leading cause of cancer deaths globally, with EGFR mutations being a common…
About 30% of lung cancer patients are accessible to targeted therapy or immunotherapy based on…
Researchers from the University of Liverpool and Queen Mary University of London, UK, have published the…
Ann & Robert H. Lurie Children’s Hospital of Chicago, USA, is pleased to announce the…
Moffitt Cancer Center has launched a pioneering clinical trial for patients with late-stage non-small cell lung cancer whose…
A new study has found that by offering stop smoking support as part of the…
A new study examines the development of two machine learning models to classify the immunophenotype…
A specific genetic alteration, known as an ALK fusion, drives non-small cell lung cancer in…
The research has demonstrated remarkable potential of tai chi as a non-pharmacological intervention for improving…